Identification of novel genetic causes of Rett syndrome-like phenotypes

Background The aim of this work was to identify new genetic causes of Rett-like phenotypes using array comparative genomic hybridisation and a whole exome sequencing approach. Methods and results We studied a cohort of 19 Portuguese patients (16 girls, 3 boys) with a clinical presentation significantly overlapping Rett syndrome (RTT). Genetic analysis included filtering of the single nucleotide variants and indels with preference for de novo, homozygous/compound heterozygous, or maternally inherited X linked variants. Examination by MRI and muscle biopsies was also performed. Pathogenic genomic imbalances were found in two patients (10.5%): an 18q21.2 deletion encompassing four exons of the TCF4 gene and a mosaic UPD of chromosome 3. Variants in genes previously implicated in neurodevelopmental disorders (NDD) were identified in six patients (32%): de novo variants in EEF1A2, STXBP1 and ZNF238 were found in three patients, maternally inherited X linked variants in SLC35A2, ZFX and SHROOM4 were detected in two male patients and one homozygous variant in EIF2B2 was detected in one patient. Variants were also detected in five novel NDD candidate genes (26%): we identified de novo variants in the RHOBTB2, SMARCA1 and GABBR2 genes; a homozygous variant in EIF4G1; compound heterozygous variant in HTT. Conclusions Network analysis reveals that these genes interact by means of protein interactions with each other and with the known RTT genes. These findings expand the phenotypical spectrum of previously known NDD genes to encompass RTT-like clinical presentations and identify new candidate genes for RTT-like phenotypes.

[1]  Michael R. Johnson,et al.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.

[2]  Gigyf Fbxo.  Monogenic Parkinson ' s disease and parkinsonism : Clinical phenotypes and frequencies of known mutations , 2017 .

[3]  W. Kaufmann,et al.  Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome , 2015, American journal of medical genetics. Part A.

[4]  T. Matsuishi,et al.  De novo SHANK3 mutation causes Rett syndrome‐like phenotype in a female patient , 2015, American journal of medical genetics. Part A.

[5]  R. Borgatti,et al.  A de-novo STXBP1 gene mutation in a patient showing the Rett syndrome phenotype , 2015, Neuroreport.

[6]  Ulf Gyllensten,et al.  CanvasDB: a local database infrastructure for analysis of targeted- and whole genome re-sequencing projects , 2014, Database J. Biol. Databases Curation.

[7]  Epilepsy Phenome,et al.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.

[8]  A. Hoischen,et al.  A de novo non-sense mutation in ZBTB18 in a patient with features of the 1q43q44 microdeletion syndrome , 2013, European Journal of Human Genetics.

[9]  Oksana Berezovska,et al.  MeCP2: a novel Huntingtin interactor. , 2014, Human molecular genetics.

[10]  S. Bardien,et al.  EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa , 2014, Neurobiology of Aging.

[11]  J. Shendure,et al.  A de novo convergence of autism genetics and molecular neuroscience , 2014, Trends in Neurosciences.

[12]  Judith A. Blake,et al.  The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse , 2013, Nucleic Acids Res..

[13]  Deanna M. Church,et al.  ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..

[14]  S. Holder,et al.  Interstitial 3p25 deletion in a patient with features of 3p deletion syndrome: further evidence for the role of SRGAP3 in mental retardation. , 2014, Clinical dysmorphology.

[15]  Y. Wada,et al.  De Novo Mutations in SLC35A2 Encoding a UDP‐Galactose Transporter Cause Early‐Onset Epileptic Encephalopathy , 2013, Human mutation.

[16]  Nancy Y. Villa,et al.  Human Eukaryotic Initiation Factor 4G (eIF4G) Protein Binds to eIF3c, -d, and -e to Promote mRNA Recruitment to the Ribosome* , 2013, The Journal of Biological Chemistry.

[17]  U. Muthane,et al.  VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians , 2013, Neurobiology of Aging.

[18]  B. Peters,et al.  Truncating mutations of MAGEL2cause Prader-Willi phenotypes and autism , 2013, Nature Genetics.

[19]  P. Fergelot,et al.  Expanding the clinical phenotype at the 3q13.31 locus with a new case of microdeletion and first characterization of the reciprocal duplication. , 2013, Molecular genetics and metabolism.

[20]  M. Mehler,et al.  Functions of Huntingtin in Germ Layer Specification and Organogenesis , 2013, PloS one.

[21]  I. Scheffer,et al.  Head stereotypies in STXBP1 encephalopathy , 2013, Developmental medicine and child neurology.

[22]  M. Bayfield,et al.  Conservation of RNA chaperone activity of the human La-related proteins 4, 6 and 7. , 2013 .

[23]  K. Veeramah,et al.  Exome sequencing reveals new causal mutations in children with epileptic encephalopathies , 2013, Epilepsia.

[24]  Ludmila Kousoulidou,et al.  263.4 kb deletion within the TCF4 gene consistent with Pitt-Hopkins syndrome, inherited from a mosaic parent with normal phenotype. , 2013, European journal of medical genetics.

[25]  Anna Gambin,et al.  Application of custom-designed oligonucleotide array CGH in 145 patients with autistic spectrum disorders , 2012, European Journal of Human Genetics.

[26]  K. Xia,et al.  Analysis of EIF4G1 in ethnic Chinese , 2013, BMC Neurology.

[27]  Emily H Turner,et al.  Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation. , 2013, American journal of human genetics.

[28]  J. Deragon,et al.  The association of a La module with the PABP-interacting motif PAM2 is a recurrent evolutionary process that led to the neofunctionalization of La-related proteins. , 2013, RNA.

[29]  M. Farrer,et al.  Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia , 2013, Acta Neuropathologica.

[30]  Bradley P. Coe,et al.  Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.

[31]  M. Forrest,et al.  Functional analysis of TCF4 missense mutations that cause Pitt–Hopkins syndrome , 2012, Human mutation.

[32]  R. Guerrini,et al.  Epilepsy in Rett syndrome, and CDKL5‐ and FOXG1‐gene–related encephalopathies , 2012, Epilepsia.

[33]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[34]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[35]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[36]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[37]  S. Steinberg,et al.  Rate of de novo mutations and the importance of father’s age to disease risk , 2012, Nature.

[38]  Toshiro K. Ohsumi,et al.  Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries , 2012, Cell.

[39]  M. Rudnicki,et al.  Snf2l regulates Foxg1-dependent progenitor cell expansion in the developing brain. , 2012, Developmental cell.

[40]  A. Bosserhoff,et al.  Nucleosome Remodeler SNF2L Suppresses Cell Proliferation and Migration and Attenuates Wnt Signaling , 2012, Molecular and Cellular Biology.

[41]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[42]  Kara L Hamilton-Nelson,et al.  Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci , 2012, Molecular Autism.

[43]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[44]  Joseph K. Pickrell,et al.  A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes , 2012, Science.

[45]  F. Saudou,et al.  Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway , 2012, Neurobiology of Disease.

[46]  A. Afenjar,et al.  Novel comprehensive diagnostic strategy in Pitt–Hopkins syndrome: Clinical score and further delineation of the TCF4 mutational spectrum , 2012, Human mutation.

[47]  M. Avoli,et al.  Genes in infantile epileptic encephalopathies -- Jasper's Basic Mechanisms of the Epilepsies , 2012 .

[48]  Keiichi I. Nakayama,et al.  Histone H1 Recruitment by CHD8 Is Essential for Suppression of the Wnt–β-Catenin Signaling Pathway , 2011, Molecular and Cellular Biology.

[49]  Wei Chen,et al.  Deep sequencing reveals 50 novel genes for recessive cognitive disorders , 2011, Nature.

[50]  C. Depienne,et al.  STXBP1‐related encephalopathy presenting as infantile spasms and generalized tremor in three patients , 2011, Epilepsia.

[51]  C. Sander,et al.  Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.

[52]  R. Pettinato,et al.  The Pitt‐Hopkins syndrome: Report of 16 new patients and clinical diagnostic criteria , 2011, American journal of medical genetics. Part A.

[53]  Kathryn Roeder,et al.  Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.

[54]  F. Alkuraya,et al.  A TCTN2 mutation defines a novel Meckel Gruber syndrome locus , 2011, Human mutation.

[55]  Matthew J. Brauer,et al.  Mapping the NPHP-JBTS-MKS Protein Network Reveals Ciliopathy Disease Genes and Pathways , 2011, Cell.

[56]  P. Thuras,et al.  Deficits in GABAB receptor system in schizophrenia and mood disorders: A postmortem study , 2011, Schizophrenia Research.

[57]  J. Lacaille,et al.  Intellectual disability without epilepsy associated with STXBP1 disruption , 2011, European Journal of Human Genetics.

[58]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[59]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[60]  J. Rosenfeld,et al.  High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44 , 2011, Human Genetics.

[61]  C. Depienne,et al.  Genes in infantile epileptic encephalopathies , 2010 .

[62]  W. Kaufmann,et al.  Rett syndrome: Revised diagnostic criteria and nomenclature , 2010, Annals of neurology.

[63]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[64]  Serafim Batzoglou,et al.  Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..

[65]  G. Kozlov,et al.  La-Related Protein 4 Binds Poly(A), Interacts with the Poly(A)-Binding Protein MLLE Domain via a Variant PAM2w Motif, and Can Promote mRNA Stability , 2010, Molecular and Cellular Biology.

[66]  I. Scheffer,et al.  Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations , 2010, Neurology.

[67]  Jana Marie Schwarz,et al.  MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.

[68]  A. Valencia,et al.  Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. , 2010, American journal of human genetics.

[69]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[70]  Christian Gilissen,et al.  De novo mutations of SETBP1 cause Schinzel-Giedion syndrome , 2010, Nature Genetics.

[71]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[72]  J. Downing,et al.  Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. , 2010, Blood.

[73]  K. Pollard,et al.  Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.

[74]  Vivian G. Cheung,et al.  Genetic analysis of radiation-induced changes in human gene expression , 2009, Nature.

[75]  Manuel Corpas,et al.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.

[76]  K. Hirschhorn,et al.  Clinical Utility of Array CGH for the Detection of Chromosomal Imbalances Associated with Mental Retardation and Multiple Congenital Anomalies , 2009, Annals of the New York Academy of Sciences.

[77]  P. Thuras,et al.  Expression of GABAB Receptors Is Altered in Brains of Subjects with Autism , 2009, The Cerebellum.

[78]  Sjoerd J. Vosse,et al.  Across array comparative genomic hybridization: A strategy to reduce reference channel hybridizations , 2008, Genes, chromosomes & cancer.

[79]  David Warde-Farley,et al.  GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function , 2008, Genome Biology.

[80]  Naomichi Matsumoto,et al.  De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy , 2008, Nature Genetics.

[81]  A. Hartemink,et al.  Computational and experimental identification of novel human imprinted genes. , 2007, Genome research.

[82]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[83]  C. Yau,et al.  QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data , 2007, Nucleic acids research.

[84]  A. Federico,et al.  The spectrum of mutations for the diagnosis of vanishing white matter disease , 2006, Neurological Sciences.

[85]  W. Gerald,et al.  Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. , 2006, Cancer research.

[86]  P. Sokoloff,et al.  Linkage with the Ser9Gly DRD3 polymorphism in essential tremor families , 2006, Clinical Genetics.

[87]  Modesto Orozco,et al.  PMUT: a web-based tool for the annotation of pathological mutations on proteins , 2005, Bioinform..

[88]  N. Kobayashi,et al.  DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways. , 2005, Journal of molecular biology.

[89]  F. Speleman,et al.  Rapid detection of VHL exon deletions using real-time quantitative PCR , 2005, Laboratory Investigation.

[90]  J. Gécz,et al.  Disruptions of the novel KIAA1202 gene are associated with X-linked mental retardation , 2005, Human Genetics.

[91]  C. Carpenter,et al.  RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex. , 2004, Genes & development.

[92]  P. Stenson,et al.  Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.

[93]  D. Bartsch,et al.  The novel Rho-GTPase activating gene MEGAP/ srGAP3 has a putative role in severe mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[94]  A. Fukui,et al.  Nuclear Localization of Duplin, a β-Catenin-binding Protein, Is Essential for Its Inhibitory Activity on the Wnt Signaling Pathway* , 2002, The Journal of Biological Chemistry.

[95]  B. Hagberg.  Clinical manifestations and stages of Rett syndrome. , 2002, Mental retardation and developmental disabilities research reviews.

[96]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[97]  C. Brannan,et al.  Expression and imprinting of MAGEL2 suggest a role in Prader-willi syndrome and the homologous murine imprinting phenotype. , 2000, Human molecular genetics.

[98]  E. Hawrot,et al.  The metabotropic GABA receptor: molecular insights and their functional consequences , 2000, Cellular and Molecular Life Sciences CMLS.

[99]  M. Gill,et al.  European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. , 1998, American journal of medical genetics.

[100]  T. Gibson,et al.  The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. , 1996, Trends in biochemical sciences.

[101]  A. Joyner,et al.  Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.

[102]  R. Treisman,et al.  The POZ domain: a conserved protein-protein interaction motif. , 1994, Genes & development.

[103]  A. Reiss,et al.  Neuroanatomy of Rett syndrome: A volumetric imaging study , 1993, Annals of neurology.

[104]  V. Blinov,et al.  Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes. , 1989, Nucleic acids research.